Compositions containing ansamycin

Details for Australian Patent Application No. 2006320435 (hide)

Owner Conforma Therapeutics Corporation

Inventors Mansfield, Robert K.; Ulm, Edgar H.

Agent Spruson & Ferguson

Pub. Number AU-A-2006320435

PCT Pub. Number WO2007/064926

Priority 60/742,093 01.12.05 US

Filing date 30 November 2006

Wipo publication date 7 June 2007

International Classifications

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/064926 Priority application(s): WO2007/064926

4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006320440-Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis

2006320431-Interlayers for laminated safety glass with superior de-airing and laminating properties and process for making the same